Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of the Utility of 18F-FLT-PET and Diffusion-Weighted MRI for Surgical Planning, Radiotherapy Target Delineation, and Treatment Response Evaluation in Ewing Sarcoma Patients

NCT01825902 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT01825902
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01825902 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of the Utility of 18F-FLT-PET and Diffusion-Weighted MRI for Surgical Planning, Radiotherapy Target Delineation, and Treatment Response Evaluation in Ewing Sarcoma Patients
Lead sponsor
Mayo Clinic
Phase
Phase 1
Overall status
Completed
Start date
March 31, 2013
Completion date
November 23, 2015
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adult supratentorial primitive neuroectodermal tumor (pnet), ewing sarcoma of bone, extraosseous ewing sarcoma, localized ewing sarcoma/peripheral primitive neuroectodermal tumor, metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor, untreated childhood supratentorial primitive neuroectodermal tumor